Role of Ocrelizumab in modulating gene and microRNA expression in multiple sclerosis
Multiple sclerosis is an autoimmune neurodegenerative disease and one of the most significant challenges in modern neurology, impacting approximately 2.8 million people globally. As a multifactorial condition, susceptibility to MS can result from a combination of genetic and environmental factors. C...
Saved in:
| Main Authors: | Bruna De Felice, Elisabetta Signoriello, Concetta Montanino, Giuseppe Romano, Deborah Archetto, Elisabetta Maida, Martina Marciano, Simona Bonavita, Giacomo Lus, Federica Farinella, Cinzia Coppola |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
KeAi Communications Co., Ltd.
2025-08-01
|
| Series: | Non-coding RNA Research |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2468054025000575 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Kappa free light chain concentration in serum is reduced after CD20-depletion with ocrelizumab
by: Franz Felix Konen, et al.
Published: (2025-08-01) -
Real-World Persistence with Ocrelizumab in Multiple Sclerosis: a Systematic Review
by: John L. Petrie, et al.
Published: (2024-10-01) -
Exploring the complex interplay between oral Fusobacterium nucleatum infection, periodontitis, and robust microRNA induction, including multiple known oncogenic miRNAs
by: Syam Jeepipalli, et al.
Published: (2025-07-01) -
Circulating microRNA profiles are associated with acute pain and stress in castrated and tail docked lambs
by: Ryan J. Farr, et al.
Published: (2025-06-01) -
Persistence to Ocrelizumab Compared with Other Disease-Modifying Therapies for Multiple Sclerosis: Results from the German NeuroTransData Registry
by: Stefan Braune, et al.
Published: (2025-06-01)